Drug Shortage Report for DICLOFENAC
| Report ID | 128917 |
| Drug Identification Number | 02475065 |
| Brand name | DICLOFENAC |
| Common or Proper name | Diclofenac Sodium Ophthalmic Solution |
| Company Name | PHARMA STULLN INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DICLOFENAC SODIUM |
| Strength(s) | 0.1% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | Diclofenac 0.1% Box 50xUD 0.3ml (PF) |
| ATC code | S01BC |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-11-26 |
| Estimated end date | 2020-12-22 |
| Actual end date | 2020-12-31 |
| Shortage status | Resolved |
| Updated date | 2021-01-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6500 TRANS CANADA HIGHWAY, SUITE 400 POINTE-CLAIRE, QUEBEC CANADA H9R 0A5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-01-02 | French | Compare |
| v4 | 2021-01-02 | English | Compare |
| v3 | 2020-11-27 | English | Compare |
| v2 | 2020-11-26 | French | Compare |
| v1 | 2020-11-26 | English | Compare |
Showing 1 to 5 of 5